Benzodiazepine dependence
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The disproportionately large occupancy change at low diazepam doses is consistent with the clinical observation of increasing withdrawal severity near zero.
“At low doses, small reductions have disproportionately large effects; for example, 5 to 0 mg changes occupancy by 16.8 p.p., exceeding the change from 100 to 50 mg (13.3 p.p.), consistent with the clinical observation of increasing withdrawal severity near zero (Ashton, 2004).”
From Pharmacological principles for safe benzodiazepine and Z-drug dose reduction (2026) · cites this paper as Ashton, 2004
A 1 mg reduction is generally tolerable from 20 mg diazepam but not from 5 mg, where smaller decrements are preferred.
“For example, it has been observed that 1 mg reductions are generally tolerable from 20 mg diazepam but not from 5 mg, where smaller decrements are preferred (Ashton, 2004), suggesting a hyperbolic relationship between dose reduction and withdrawal severity.”
From Pharmacological principles for safe benzodiazepine and Z-drug dose reduction (2026) · cites this paper as Ashton, 2004
Withdrawal symptoms are hyperbolically dose-dependent: larger reductions cause greater severity, particularly at lower doses.
“Withdrawal symptoms also appear to be hyperbolically dose-dependent: larger reductions cause greater severity, particularly at lower doses (Ashton, 2004).”
From Pharmacological principles for safe benzodiazepine and Z-drug dose reduction (2026) · cites this paper as Ashton, 2004
A 5 to 0 mg diazepam reduction changes GABA-A occupancy by 16.8 percentage points, exceeding the change from 100 to 50 mg (13.3 p.p.).
“At low doses, small reductions have disproportionately large effects; for example, 5 to 0 mg changes occupancy by 16.8 p.p., exceeding the change from 100 to 50 mg (13.3 p.p.), consistent with the clinical observation of increasing withdrawal severity near zero (Ashton, 2004).”
From Pharmacological principles for safe benzodiazepine and Z-drug dose reduction (2026) · cites this paper as Ashton, 2004
Cited by
Sorted by citations
The diagnosis and management of benzodiazepine dependence
Ashton, H. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165594.60434.84 · Cited by 455 · see citing works
Self-citationAragona, M., Onesti, E., Tomassini, V., Conte, A., Gupta, S., Gilio, F., Pantano, P., Pozzilli, C., & Inghilleri, M. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181633497 · Cited by 109 · see citing works
Benzodiazepine dependence: Focus on withdrawal syndrome
Authier, N., Balayssac, D., Sautereau, M., Zangarelli, A., Courty, P., Somogyi, A. A., Vennat, B., Llorca, P.-M., & Eschalier, A. (2009) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2009.07.001 · Cited by 79 · see citing works
Saunders, J. B. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01589.x · Cited by 63 · see citing works
Pharmacological principles for safe benzodiazepine and Z-drug dose reduction
Horowitz, M., Lamberson, N., Brandt, J., Framer, A., Shapiro, B., Sørensen, A., Cadogan, C., Ritvo, A., & Taylor, D. (2026) · Psychological Medicine · doi:10.1017/s0033291726104887
- Authors
- Ashton, H.
- Corresponding author
- Ashton, Heather
- Venue
- Adverse Syndromes and Psychiatric Drugs
- Publisher
- Oxford University Press
- Published
- 2004-05
- Pages
- 239-260
- OpenAlex
- W4252235324
- Cited by
- 25
- References
- 0
- Citations by year
- 2026: 1 · 2024: 2 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 1 · 2013: 1 · 2012: 1
- FWCI
- 5.72
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Oxford University Press eBooks (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and pharmacology of benzodiazepine derivatives
- Keywords
- benzodiazepine dependence, benzodiazepines, substance use disorders, drug addiction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review